The patient safety profile of a non-rebreather mask (NRBM) has been a matter of concern for some time; however, there is very little reference to these performance characteristics in the literature ([@b1-cjrt-52-13]--[@b3-cjrt-52-13]). Low-flow characteristics and a potential lack of effective washout of exhaled gases can lead to rebreathing of carbon dioxide (CO~2~) in certain conditions ([@b1-cjrt-52-13]--[@b3-cjrt-52-13]). This concern has previously led to aftermarket modifications to the NRBM by way of removing one of the one-way valves that are located on either side of the mask. This modification is intended to reduce or attenuate the rebreathing of exhaled gasses and potential for hypercarbic respiratory failure and lower fraction of inspired oxygen (F~i~O~2~) leading to hypoxemia. These conditions may exist when the mask flow is set inadvertently low, is accidently disconnected from its fresh gas source or the very small exhalation port is obstructed ([@b2-cjrt-52-13],[@b4-cjrt-52-13]). We hypothesized that the open design of the OxyMask^TM^ (Southmedic Inc, Canada) would mitigate these concerns by allowing for less CO~2~ rebreathing while delivering inspired oxygen levels that compare favourably with the Hudson RCI^®^ NRBM^TM^ (Teleflex Inc, USA) ([@b5-cjrt-52-13]--[@b7-cjrt-52-13]).

METHODS
=======

The CO~2~ source was attached to the inhalation limb of the Harvard Pump (Harvard Apparatus, USA) on the piston side of the inhalation check valve. A 0.125 inch OD sensing oxygen line was attached to the head and the sensing end was positioned 1 inch into the 0.875 inch ID simulated oral cavity of the mannequin. Gas sampling was achieved through the line to the oxygen and CO~2~ sensor (10 mL/min each) using a vacuum source. End tidal CO~2~ (EtCO~2~) values were set without the mask in place so as to simulate normal expected breathing. The CO~2~ flow was set to the desired settings ([Table 1](#t1-cjrt-52-13){ref-type="table"}). Once CO~2~ flow had been set to the desired EtCO~2~ value, the mask was adjusted to the desired oxygen flow rate (2 L/min and 15 L/min, respectively) and placed on the mannequin head as designed. The system was allowed to equilibrate for at least 3 min before obtaining each reading. Each sample was tested three times. The mask was removed from the mannequin head completely and repositioned between each test. Each mask was tested at three different respiratory rates and minute volumes: 15 breaths/min, 20 breaths/min and 24 breaths/min. Each of these conditions were simulated at both 2 L/min of oxygen flow or 15 L/min of oxygen flow. There were a total of 36 tests (2 samples × 3 tests per sample × 2 oxygen flow settings × 3 respiratory settings = 36 tests total). After allowing each setting 3 min to equilibrate a full inhalation and exhalation CO~2~ waveform, EtCO~2~ and FiO~2~ measurements were captured. Performance of each device was evaluated and qualified in terms of each mask's ability to clear CO~2~ from the mask during exhalation. All equipment and laboratory processes met their specifications and requirements before and after testing. CO~2~ measurements were calibrated before testing at 0% and 5%. Oxygen measurements were calibrated at 21% and 100% before testing. After testing, calibration curves were verified. The equipment list and patient simulation set-up are listed and described in [Appendix 1](#app1){ref-type="app"}, and [Figures 1](#f1-cjrt-52-13){ref-type="fig"} and [2](#f2-cjrt-52-13){ref-type="fig"}, respectively.

Statistical analysis
--------------------

All analyses were performed using SPSS version 20.0 (IBM Corporation, USA) for Windows (Microsoft Corporation, USA). Descriptive statistics were examined and reported for continuous data as means and SD. Differences between means were assessed using multivariate ANOVA to determine the effect of the three respiratory rates (15, 20 and 24 breaths/min) and two oxygen flows (2 L/min and 15 L/min) on four dependent variables. Significant differences among the covariates were assessed using Wilks' λ. All statistical tests were two-tailed and based on a 0.05 significance level.

RESULTS
=======

[Table 2](#t2-cjrt-52-13){ref-type="table"} summarizes combined mean data collected while testing both masks with oxygen flow rates of 2 L/min and 15 L/min and respiratory rates of 15, 20 and 24 breaths/min. [Table 3](#t3-cjrt-52-13){ref-type="table"} summarizes mean data for each individual test. The OxyMask delivered more or an equivalent amount of oxygen compared with the NRBM at the same conditions. The OxyMask resulted in lower or equivalent EtCO~2~ levels compared with the NRBM at the same conditions. CO~2~ levels dropped faster during exhalation with the OxyMask than with the NRBM. Performance of the two products tended to be farther apart at lower flow rates of oxygen. Significant differences among the covariates were noted (F=14.56; P\<0.001; λ=0.332). When controlling for device flow and respiratory rate, there was a statistically significant effect on EtCO~2~ (F=29.37; P\<0.001), O~2~ (F=24.17;P\<0.001), inhaled O~2~ (F=54.60; P\<0.001) and percent drop in CO~2~ (F=41.72; P\<0.001).

DISCUSSION
==========

Patient safety is paramount. It has been historically hypothesized that the use of an NRBM may be unsafe when certain elements exist that create conditions favourable for rebreathing CO~2~ ([@b7-cjrt-52-13]--[@b10-cjrt-52-13]). The literature supporting this notion is virtually nonexistent. Our bench report comparing the Southmedic OxyMask^TM^ and the Hudson RCI^®^ NRBM^TM^ has taken a step toward answering this question. First, we chose parameters that were believed to be appropriate surrogates of common patient conditions. Inhaled and exhaled oxygen levels, as well as CO~2~ levels, were measured. Subsequently, varying patient and equipment conditions were introduced by way of changing respiratory rates and oxygen flow rates. Higher oxygen flow rates (15 L/min) were chosen to simulate the standard practice with both masks. Lower oxygen flow rates (2 L/min) were used to simulate an inadvertent decrease from the standard. Increasing respiratory rates were tested to simulate a change in patient condition and minute volume. Our experiments demonstrated, that when the NRBM and OxyMask are used as per the standard (higher flows), they are safe oxygen delivery masks and deliver a relatively high and stable level of inspired oxygen. Additionally, CO~2~ appears to be adequately cleared under these conditions. Alternatively, when tested at lower flow rates, the OxyMask appears to outperform the NRBM in terms of CO~2~ clearance and at delivering inspired oxygen.

There were limitations to the present study. Although the measurements obtained during these experiments show a statistical significance almost across the board in favour of the OxyMask at lower flow rates, the sample numbers are low and further evaluation may be helpful to suggest a change in safe practice. We believe that our data suggests that the Southmedic OxyMask may be a safer alternative to the Hudson RCI NRBM in which conditions exist that make inadvertent low oxygen delivery flows more likely to occur.
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1.  A\) SouthMedic Adult OxyMask (SouthMedic, Barrie, Ontario)

2.  B\) Hudson RCI Adult Non-rebreathing Mask with Safety Vent (Morrisville, NC, USA)

3.  C\) 0--100 psig Pressure Gauge

4.  D\) Gilmont glass float type Rotameter (Barrington, IL, USA)

5.  E\) Low Flow Rotameter

6.  F\) AccuLAB Standard Electronic Balance TS series (Goettingen, Germany)

7.  G\) Vacuum source

8.  H\) Compressed gas source

9.  I\) Oxygen source

10. J\) CO~2~ source

11. K\) Velleman Digital Oscilloscope (Fort Worth, Texas, USA)

12. L\) Ohmeda 5200 CO~2~ Monitor (Madison, WI, USA)

13. M\) Data Acquisition System

14. N\) Humidity/Temperature Meter

15. O\) Oxygen Sensor

16. P\) Harvard Respiratory Pump (Harvard Apparatus, Holliston, Massachusetts, USA),

17. Q\) Wright Respirometer

18. R\) Adult Mannequin Head (0.875 inch ID oral cavity, head width = 6.

![The patient simulation setup used for testing. CO~2~ Carbon dioxide](cjrt-52-13-1){#f1-cjrt-52-13}

![**Left panel** *OxyMask^TM^ (Southmedic Inc, Canada).* **Right panel** *Hudson RCI^®^ Non-Rebreather Mask^TM^ (Teleflex Inc, USA)*](cjrt-52-13-2){#f2-cjrt-52-13}

###### 

Three respiratory settings used for testing

  **Parameter**                   **Setting**         
  ------------------------------- ------------- ----- -----
  Respiratory rate, breaths/min   15            20    24
  Tidal volume, mL                400           400   400
  Inspiratory:expiratory ratio    1:2           1:2   1:2
  End tidal carbon dioxide, %     5             5     5

###### 

Data collected testing both masks

  **Parameter**              **Southmedic OxyMask^TM^**   **Hudson RCI**^®^ **NRB Mask^TM^**   **F**   **P**
  -------------------------- ---------------------------- ------------------------------------ ------- ---------
  End tidal carbon dioxide   5.2±0.35                     5.8±0.61                             29.37   \<0.001
  Oxygen                     61.8±16.17                   57.0±19.03                           24.17   \<0.001
  Inhaled carbon dioxide     2.2±.52                      3.0±1.13                             54.60   \<0.001
  \% drop                    83.1±6.85                    63.8±13.52                           41.72   \<0.001

Data presented as mean ± SD unless otherwise indicated

  **Device**                                                    **Flow rate, L/min**   **Respiratory rate, breaths/min**   **End tidal carbon dioxide**   **Oxygen**   **Inhaled carbon dioxide**   **Drop in carbon dioxide in first second of exhalation**
  ------------------------------------------------------------- ---------------------- ----------------------------------- ------------------------------ ------------ ---------------------------- ----------------------------------------------------------
  OxyMask^TM[\*](#tfn3-cjrt-52-13){ref-type="table-fn"}^        2                      15                                  5.2±0.1                        52.1±1.6     2.1±0.1                      74.0±6.4
  Hudson RCI NRBM^[†](#tfn4-cjrt-52-13){ref-type="table-fn"}^   2                      15                                  5.8±0.1                        44.1±0.6     3.3±0.1                      41.3±5.6
  OxyMask^TM^                                                   2                      20                                  5.4±0.1                        50.5±1.1     2.7±0.1                      84.8±7.5
  Hudson RCI NRBM                                               2                      20                                  5.9±0.2                        39.7±2.0     3.6±0.1                      59.8±7.8
  OxyMask^TM^                                                   2                      24                                  5.8±0.1                        39.1±1.1     2.9±0.1                      92.5±3.3
  Hudson RCI NRBM                                               2                      24                                  6.6±0.1                        34.0±1.8     4.9±0.1                      59.0±3.8
  OxyMask^TM^                                                   15                     15                                  4.9±0.0                        84.3±1.8     1.5±0.1                      80.0±2.2
  Hudson RCI NRBM                                               15                     15                                  4.8±0.0                        82.2±3.9     1.4±0.1                      73.5±2.8
  OxyMask^TM^                                                   15                     20                                  4.9±0.1                        73.2±1.6     1.8±0.0                      84.4±2.3
  Hudson RCI NRBM                                               15                     20                                  5.1±0.2                        73.6±0.8     2.2±0.2                      80.6±3.3
  OxyMask^TM^                                                   15                     24                                  4.9±0.1                        71.9±0.9     2.1±0.1                      82.7±1.8
  Hudson RCI NRBM                                               15                     24                                  5.4±0.0                        68.6±1.0     2.8±0.0                      68.8±1.2

Data presented as mean ± SD % unless otherwise indicated.
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